Alvotech (OISE:ALVO) Stock News, Headlines & Updates
Alvotech Stock News from GuruFocus
- 1
Jun 18, 2024
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe
Marketwired • 4:00am
Jun 11, 2024
Alvotech and STADA add to strategic alliance through denosumab partnership
Marketwired • 3:00am
Jun 07, 2024
Alvotech Announces Strategic Refinancing Agreement
Marketwired • 3:00am
May 29, 2024
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
Marketwired • 8:00am
May 23, 2024
Q1 2024 Alvotech SA Earnings Call Transcript
GuruFocus Research • 3:04am
May 21, 2024
Alvotech and Dr. Reddy's enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Marketwired • 8:00am
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire • 11:00pm
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire • 11:00pm
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Marketwired • 8:00pm
May 13, 2024
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
Marketwired • 7:00am
May 02, 2024
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Marketwired • 7:00am
Apr 30, 2024
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
Marketwired • 3:00am
Apr 24, 2024
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Marketwired • 3:00am
Apr 19, 2024
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Marketwired • 6:00am
Apr 16, 2024
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
GlobeNewswire • 5:00pm
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Marketwired • 5:00pm
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
GlobeNewswire • 5:00pm
Apr 03, 2024
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news